AURITZ

This brand name is authorized in Nigeria.

Active ingredients

The drug AURITZ contains one active pharmaceutical ingredient (API):

1	Rosuvastatin UNII 83MVU38M7Q - ROSUVASTATIN CALCIUM
	Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.
	Read more about Rosuvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7496	Tablet	AURITZ 10 TABLETS TAB 10 mg 3 X 10, 1 X 10	91 RNW-PP-241474 AURITZ 10 TABLETS ROSUVASTATIN CALCIUM 10.4MG EQV TO ROSUVASTATIN 10MG ROSUVASTATIN CALCIUM 10.4MG EQV TO ROSUVASTATIN 10MG, MICROCRYSTALLINE CELLULOSE AVICEL PH 101 USP 108.1MG, PREGELATINIZED STARCH USPNF 15MG, CROSPOVIDONE USPNF 2.5MG, MEGLUMINE USP 2.5MG, MANNITOL USP 10MG, MAGNESIUM STEARATE USPNF 1.5MG, OPADRY PINK 4.5MG, PURIFIED WATER Q.S A4-7496 Drugs CARDIOVASCULAR SYSTEM Imported Products 310,110 Prescription Only Medicine (POM) 11/23/2021 MEGA LIFESCIENCES NIGERIA LIMITED, GUINNESS ROAD, OGBA - IKEJA OGBA LAGOS 8053596201 info.ng@megawecare.com MSN LABORATORIES PVT LTD, PLOT 42 ANRICH INDUSTRIAL ESTATE ,BOLLARAM SANGAREDDY DISTRICT 502325 TELANGANA INDIA, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA07	Rosuvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7496